# The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy

> **NCT04238208** · PHASE4 · COMPLETED · sponsor: **Corporacion Parc Tauli** · enrollment: 290 (actual)

## Conditions studied

- Diabetic Nerve Problems
- Diabetic Neuropathy
- Diabetic Complications Neurological

## Interventions

- **DRUG:** Lidocaine 5% patch
- **DRUG:** Capsaicin 8% Patch, Per 10 Square Centimeters

## Key facts

- **NCT ID:** NCT04238208
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2019-12-10
- **Final completion:** 2020-01-02
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2020-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04238208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04238208, "The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04238208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*